cabergoline

Generic: cabergoline

Labeler: ingenus pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cabergoline
Generic Name cabergoline
Labeler ingenus pharmaceuticals, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

cabergoline .5 mg/1

Manufacturer
Ingenus Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 50742-118
Product ID 50742-118_9bcb5111-ddb4-46f6-9318-e4a9d51d9e30
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204735
Listing Expiration 2026-12-31
Marketing Start 2018-08-09

Pharmacologic Class

Established (EPC)
ergot derivative [epc]
Chemical Structure
ergolines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50742118
Hyphenated Format 50742-118

Supplemental Identifiers

RxCUI
199703
UPC
0350742118083
UNII
LL60K9J05T
NUI
M0007652 N0000175827

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cabergoline (source: ndc)
Generic Name cabergoline (source: ndc)
Application Number ANDA204735 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 8 TABLET in 1 BOTTLE (50742-118-08)
source: ndc

Packages (1)

Ingredients (1)

cabergoline (.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9bcb5111-ddb4-46f6-9318-e4a9d51d9e30", "openfda": {"nui": ["M0007652", "N0000175827"], "upc": ["0350742118083"], "unii": ["LL60K9J05T"], "rxcui": ["199703"], "spl_set_id": ["57cbd81e-fdb9-4060-80ee-6e8581c463a4"], "pharm_class_cs": ["Ergolines [CS]"], "pharm_class_epc": ["Ergot Derivative [EPC]"], "manufacturer_name": ["Ingenus Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "8 TABLET in 1 BOTTLE (50742-118-08)", "package_ndc": "50742-118-08", "marketing_start_date": "20180809"}], "brand_name": "Cabergoline", "product_id": "50742-118_9bcb5111-ddb4-46f6-9318-e4a9d51d9e30", "dosage_form": "TABLET", "pharm_class": ["Ergolines [CS]", "Ergot Derivative [EPC]"], "product_ndc": "50742-118", "generic_name": "Cabergoline", "labeler_name": "Ingenus Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cabergoline", "active_ingredients": [{"name": "CABERGOLINE", "strength": ".5 mg/1"}], "application_number": "ANDA204735", "marketing_category": "ANDA", "marketing_start_date": "20180809", "listing_expiration_date": "20261231"}